Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946530 · ClinicalTrials.gov registry record · NA
Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
NCT00946530: Completed NA study, sponsored by Stanford University.
NCT00946530 is a NA study that has completed, run by Stanford University. The registered enrollment target is 118 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00946530, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
Study Summary
The aim of this study is to demonstrate the efficacy of timed exposure to bright light for the treatment of disturbed nighttime sleep and daytime wake in community-dwelling dementia patients and their caregivers, and to determine if there are genetic relationships between memory problems and sleep problems
Primary Outcome
The amount of actual sleep time in a sleep episode.
Interventions
- DEVICE Control
- DEVICE Bright light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2004-09 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT00946530 record still lists
NCT00946530 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00946530 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00946530 about?
NCT00946530 is a clinical study titled "Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease". The aim of this study is to demonstrate the efficacy of timed exposure to bright light for the treatment of disturbed nighttime sleep and daytime wake in community-dwelling dementia patients and their caregivers, and to determine if there are genetic relationships between memory problems and sleep p...
What is the current status of trial NCT00946530?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2004-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00946530?
The interventions under investigation include: Control (DEVICE), Bright light (DEVICE).
Who is sponsoring clinical trial NCT00946530?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00946530's enrollment target sits among peer trials
118 803rd of 2000 higher than 1,194 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia